Jacob Jameson 📊
@jacobjameson.com
PhD candidate Harvard Decision Science ⚖️ 🏥 | T32 Predoc Comparative Effectiveness Research for Suicide Prevention | Causal Inference 📈, Reinforcement Learning 🧠, Modeling 💻, Teaching 👨🏻🏫, Reproducibility 🐳
Jacobjameson.com
Jacobjameson.com
Reposted by Jacob Jameson 📊
Congratulations to CHDS's @jacobjameson.com and all the finalists!
Excited to be named a finalist for the INFORMS Health Applications Society student paper competition for my paper on discretionary image batching in the emergency department!
Paper here 👇
papers.ssrn.com/sol3/papers....
Paper here 👇
papers.ssrn.com/sol3/papers....
September 17, 2025 at 9:00 PM
Congratulations to CHDS's @jacobjameson.com and all the finalists!
Excited to be named a finalist for the INFORMS Health Applications Society student paper competition for my paper on discretionary image batching in the emergency department!
Paper here 👇
papers.ssrn.com/sol3/papers....
Paper here 👇
papers.ssrn.com/sol3/papers....
September 17, 2025 at 2:19 PM
Excited to be named a finalist for the INFORMS Health Applications Society student paper competition for my paper on discretionary image batching in the emergency department!
Paper here 👇
papers.ssrn.com/sol3/papers....
Paper here 👇
papers.ssrn.com/sol3/papers....
Reposted by Jacob Jameson 📊
Losing a friend. Older men have the highest suicide rate of any demographic group. This challenge doesn't get nearly the attention it should. www.chicagotribune.com/2025/08/13/o...
Harold Pollack: I studied the high male suicide rate. Then I lost my friend to it.
We middle-aged and older men face higher suicide rates than are found among our teenage sons and grandsons, or among women at any age.
www.chicagotribune.com
August 13, 2025 at 11:43 AM
Losing a friend. Older men have the highest suicide rate of any demographic group. This challenge doesn't get nearly the attention it should. www.chicagotribune.com/2025/08/13/o...
New life update! Married my best friend @madisoncoots.com
July 26, 2025 at 6:42 PM
New life update! Married my best friend @madisoncoots.com
Reposted by Jacob Jameson 📊
Check out this new article by CHDS doctoral student @jacobjameson.com and colleagues
🚨 NEW in American Journal of Preventive Medicine with Nate Glasser, Nabil Baker, Harold Pollack, & Elizabeth Tung
We show that permissive state firearm policies amplify sex differences in suicide—especially among young and older men
🔗 t.co/1kZ24LPkmW
We show that permissive state firearm policies amplify sex differences in suicide—especially among young and older men
🔗 t.co/1kZ24LPkmW
June 30, 2025 at 9:18 PM
Check out this new article by CHDS doctoral student @jacobjameson.com and colleagues
🚨 NEW in American Journal of Preventive Medicine with Nate Glasser, Nabil Baker, Harold Pollack, & Elizabeth Tung
We show that permissive state firearm policies amplify sex differences in suicide—especially among young and older men
🔗 t.co/1kZ24LPkmW
We show that permissive state firearm policies amplify sex differences in suicide—especially among young and older men
🔗 t.co/1kZ24LPkmW
June 28, 2025 at 4:39 PM
🚨 NEW in American Journal of Preventive Medicine with Nate Glasser, Nabil Baker, Harold Pollack, & Elizabeth Tung
We show that permissive state firearm policies amplify sex differences in suicide—especially among young and older men
🔗 t.co/1kZ24LPkmW
We show that permissive state firearm policies amplify sex differences in suicide—especially among young and older men
🔗 t.co/1kZ24LPkmW
Unfortunately, one of the many the grants canceled at @Harvard.edu was my T32 in Comparative Effectiveness Research for Suicide Prevention
If you’re coming to #SMDM47 @smdm.bsky.social come see the previously funded great work we are doing related to suicide prevention
If you’re coming to #SMDM47 @smdm.bsky.social come see the previously funded great work we are doing related to suicide prevention
May 28, 2025 at 12:28 AM
Unfortunately, one of the many the grants canceled at @Harvard.edu was my T32 in Comparative Effectiveness Research for Suicide Prevention
If you’re coming to #SMDM47 @smdm.bsky.social come see the previously funded great work we are doing related to suicide prevention
If you’re coming to #SMDM47 @smdm.bsky.social come see the previously funded great work we are doing related to suicide prevention
If you’re looking to improve your collaborative workflow, computational reproducibility, or just how to make the most out of version control — this is for you 👇👇
May 15, 2025 at 5:01 PM
If you’re looking to improve your collaborative workflow, computational reproducibility, or just how to make the most out of version control — this is for you 👇👇
Reposted by Jacob Jameson 📊
If you are going to @smdm.bsky.social consider this short course with @madisoncoots.com and CHDS's @jacobjameson.com
May 14, 2025 at 6:37 PM
If you are going to @smdm.bsky.social consider this short course with @madisoncoots.com and CHDS's @jacobjameson.com
Woo 🥳 3rd consecutive year I will be teaching my reproducibility and project management short course at #SMDM annual meeting
ALSO if anyone knows any health/med journals looking to up their code sharing and reproducibility requirements please let me know 🙏
ALSO if anyone knows any health/med journals looking to up their code sharing and reproducibility requirements please let me know 🙏
March 5, 2025 at 7:31 PM
Woo 🥳 3rd consecutive year I will be teaching my reproducibility and project management short course at #SMDM annual meeting
ALSO if anyone knows any health/med journals looking to up their code sharing and reproducibility requirements please let me know 🙏
ALSO if anyone knows any health/med journals looking to up their code sharing and reproducibility requirements please let me know 🙏
🚨New in Clinical Pharmacology & Therapeutics
We find underrepresented groups have significantly lower exposure to medications with actionable PGx guidance—highlighting a critical obstacle to equitable genomically-guided personalized medicine 💊
ascpt.onlinelibrary.wiley.com/doi/10.1002/...
We find underrepresented groups have significantly lower exposure to medications with actionable PGx guidance—highlighting a critical obstacle to equitable genomically-guided personalized medicine 💊
ascpt.onlinelibrary.wiley.com/doi/10.1002/...
March 4, 2025 at 4:52 PM
🚨New in Clinical Pharmacology & Therapeutics
We find underrepresented groups have significantly lower exposure to medications with actionable PGx guidance—highlighting a critical obstacle to equitable genomically-guided personalized medicine 💊
ascpt.onlinelibrary.wiley.com/doi/10.1002/...
We find underrepresented groups have significantly lower exposure to medications with actionable PGx guidance—highlighting a critical obstacle to equitable genomically-guided personalized medicine 💊
ascpt.onlinelibrary.wiley.com/doi/10.1002/...
Reminded of a special memory: in 4th grade my best friend Zach came to school kinda down. I asked what’s wrong and he said he just listened to the saddest song and it’s got him feeling kinda down. He pulls out his iPod to have me listen to the theme song from the tv show Scrubs
February 19, 2025 at 6:18 PM
Reminded of a special memory: in 4th grade my best friend Zach came to school kinda down. I asked what’s wrong and he said he just listened to the saddest song and it’s got him feeling kinda down. He pulls out his iPod to have me listen to the theme song from the tv show Scrubs
New blog post: A Gentle Introduction to Bayesian Linear Regression in R 📊
jacobjameson.com/posts/2025-0...
jacobjameson.com/posts/2025-0...
Jacob Jameson - A Gentle Introduction to Bayesian Linear Regression in R
This guide walks you through Bayesian linear regression in R and Stan, explaining how priors, likelihoods, and posteriors work in an intuitive and hands-on way.
jacobjameson.com
February 9, 2025 at 8:29 PM
New blog post: A Gentle Introduction to Bayesian Linear Regression in R 📊
jacobjameson.com/posts/2025-0...
jacobjameson.com/posts/2025-0...
Would you rather be seen by an ED physician who orders their tests in a batch or in sequence?
👩⚕️👨⚕️🩻
New in Feb 2025 issue of HSR by Soroush Saghafian, Nicole Hodgson, Rob Huckman, and I
👩⚕️👨⚕️🩻
New in Feb 2025 issue of HSR by Soroush Saghafian, Nicole Hodgson, Rob Huckman, and I
February 5, 2025 at 2:44 PM
Would you rather be seen by an ED physician who orders their tests in a batch or in sequence?
👩⚕️👨⚕️🩻
New in Feb 2025 issue of HSR by Soroush Saghafian, Nicole Hodgson, Rob Huckman, and I
👩⚕️👨⚕️🩻
New in Feb 2025 issue of HSR by Soroush Saghafian, Nicole Hodgson, Rob Huckman, and I
"HKS researchers create an analytical framework that informs the ongoing medical debate over whether to use race-unaware or race-aware risk assessments."
@madisoncoots.com 👏👏👏
t.co/95lyhM9Md4
@madisoncoots.com 👏👏👏
t.co/95lyhM9Md4
https://www.hks.harvard.edu/faculty-research/policy-topics/health/should-race-be-used-determining-risk-disease-yes-and-no/
t.co
January 29, 2025 at 11:48 PM
"HKS researchers create an analytical framework that informs the ongoing medical debate over whether to use race-unaware or race-aware risk assessments."
@madisoncoots.com 👏👏👏
t.co/95lyhM9Md4
@madisoncoots.com 👏👏👏
t.co/95lyhM9Md4
Join our lab!
PIAS-Lab at Harvard Kennedy School is accepting new applications for a Postdoctoral Fellow position. More information can be found 👇👇👇
scholar.harvard.edu/sites/schola...
PIAS-Lab at Harvard Kennedy School is accepting new applications for a Postdoctoral Fellow position. More information can be found 👇👇👇
scholar.harvard.edu/sites/schola...
scholar.harvard.edu
January 17, 2025 at 7:39 PM
Join our lab!
PIAS-Lab at Harvard Kennedy School is accepting new applications for a Postdoctoral Fellow position. More information can be found 👇👇👇
scholar.harvard.edu/sites/schola...
PIAS-Lab at Harvard Kennedy School is accepting new applications for a Postdoctoral Fellow position. More information can be found 👇👇👇
scholar.harvard.edu/sites/schola...
Reposted by Jacob Jameson 📊
So excited this finally out!! 🥳 Thread on our new paper 👇
NEW in Management Science!
My coauthors and I came up with a new consequentialist approach to designing equitable algorithms.
Instead of imposing fairness criteria on an algorithm (like equal false negative rates), we aim for good outcomes.
More in the 🧵 below! (1/)
My coauthors and I came up with a new consequentialist approach to designing equitable algorithms.
Instead of imposing fairness criteria on an algorithm (like equal false negative rates), we aim for good outcomes.
More in the 🧵 below! (1/)
January 9, 2025 at 6:16 PM
So excited this finally out!! 🥳 Thread on our new paper 👇
Reposted by Jacob Jameson 📊
NEW in Management Science!
My coauthors and I came up with a new consequentialist approach to designing equitable algorithms.
Instead of imposing fairness criteria on an algorithm (like equal false negative rates), we aim for good outcomes.
More in the 🧵 below! (1/)
My coauthors and I came up with a new consequentialist approach to designing equitable algorithms.
Instead of imposing fairness criteria on an algorithm (like equal false negative rates), we aim for good outcomes.
More in the 🧵 below! (1/)
January 8, 2025 at 11:31 PM
NEW in Management Science!
My coauthors and I came up with a new consequentialist approach to designing equitable algorithms.
Instead of imposing fairness criteria on an algorithm (like equal false negative rates), we aim for good outcomes.
More in the 🧵 below! (1/)
My coauthors and I came up with a new consequentialist approach to designing equitable algorithms.
Instead of imposing fairness criteria on an algorithm (like equal false negative rates), we aim for good outcomes.
More in the 🧵 below! (1/)
Happy birthday to my beautiful fiancée @madisoncoots.com ❤️
December 22, 2024 at 9:00 PM
Happy birthday to my beautiful fiancée @madisoncoots.com ❤️
Reposted by Jacob Jameson 📊
🚨 Excited to share our new article in @annualreviews.bsky.social. Working with Kristin Linn, @5harad.com, Amol Navathe, and Ravi Parikh, we examine the fairness debates of seven prominent and controversial healthcare algorithms.🧵 madisoncoots.com/files/racial...
December 13, 2024 at 8:00 PM
🚨 Excited to share our new article in @annualreviews.bsky.social. Working with Kristin Linn, @5harad.com, Amol Navathe, and Ravi Parikh, we examine the fairness debates of seven prominent and controversial healthcare algorithms.🧵 madisoncoots.com/files/racial...
Reposted by Jacob Jameson 📊
The use of race in clinical risk models is heavily debated. While race-aware models can be more accurate, some are concerned about reinforcing racialized views of medicine. In our paper, we offer a new perspective on this debate. 🧵👇https://annals.org/aim/article/doi/10.7326/M23-3166
December 5, 2024 at 7:02 PM
The use of race in clinical risk models is heavily debated. While race-aware models can be more accurate, some are concerned about reinforcing racialized views of medicine. In our paper, we offer a new perspective on this debate. 🧵👇https://annals.org/aim/article/doi/10.7326/M23-3166
Final office hours today for MPP microeconomics at the Kennedy school. Absolutely packed!
December 4, 2024 at 11:19 PM
Final office hours today for MPP microeconomics at the Kennedy school. Absolutely packed!
Reposted by Jacob Jameson 📊
Using race in medical risk assessments is hotly debated, with some arguing that doing so improves accuracy while others worry it reinforce pernicious attitudes. With @madisoncoots.com and colleagues, we identify a statistical twist that's been largely overlooked. 5harad.com/papers/race-...
December 4, 2024 at 12:57 PM
Using race in medical risk assessments is hotly debated, with some arguing that doing so improves accuracy while others worry it reinforce pernicious attitudes. With @madisoncoots.com and colleagues, we identify a statistical twist that's been largely overlooked. 5harad.com/papers/race-...
Reposted by Jacob Jameson 📊
1/10🚨 New Findings Alert! 🚨
Discover how genomic heterogeneity and ploidy help predict intrinsic resistance to anti-PD-1 immune checkpoint blockade (ICB) in metastatic melanoma. 🧬https://www.science.org/doi/10.1126/sciadv.adp4670
📝 Key takeaways from our latest study: 🧵👇
Discover how genomic heterogeneity and ploidy help predict intrinsic resistance to anti-PD-1 immune checkpoint blockade (ICB) in metastatic melanoma. 🧬https://www.science.org/doi/10.1126/sciadv.adp4670
📝 Key takeaways from our latest study: 🧵👇
November 29, 2024 at 9:43 PM
1/10🚨 New Findings Alert! 🚨
Discover how genomic heterogeneity and ploidy help predict intrinsic resistance to anti-PD-1 immune checkpoint blockade (ICB) in metastatic melanoma. 🧬https://www.science.org/doi/10.1126/sciadv.adp4670
📝 Key takeaways from our latest study: 🧵👇
Discover how genomic heterogeneity and ploidy help predict intrinsic resistance to anti-PD-1 immune checkpoint blockade (ICB) in metastatic melanoma. 🧬https://www.science.org/doi/10.1126/sciadv.adp4670
📝 Key takeaways from our latest study: 🧵👇